Advertisement
MO BIO
MO BIO

The Scientist

» drug development and evolution

Most Recent

image: Book Excerpt from <em>Buddhist Biology</em>

Book Excerpt from Buddhist Biology

By | February 1, 2014

In Chapter 1, “A Science Sutra,” author David Barash describes how the ancient philosophy might form the perfect link between science and religion.

10 Comments

image: Chemistry as Art

Chemistry as Art

By | February 1, 2014

See Scientist To Watch Phil Baran describe the artistry of his research in drug discovery.

0 Comments

image: Phil Baran: Molecule Magician

Phil Baran: Molecule Magician

By | February 1, 2014

Professor, Chemistry, The Scripps Research Institute. Age: 36

1 Comment

image: Self-Improvement Through the Ages

Self-Improvement Through the Ages

By | February 1, 2014

A 50,000-generation-long experiment shows that bacteria keep getting fitter.

2 Comments

image: New River Dolphin

New River Dolphin

By | January 27, 2014

DNA sequencing study reveals a new river dolphin species in South America.

2 Comments

image: <em>Drosophila</em>’s New Genes

Drosophila’s New Genes

By | January 23, 2014

An analysis of the transcriptomes of several fruit fly strains reveals dozens of possible de novo genes in each.

6 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

image: The Shared Perfumes of Queens

The Shared Perfumes of Queens

By | January 16, 2014

Ant, bee, and wasp queens emit a similar class of pheromones that sterilize their workers, hinting at a shared ancestry for these chemicals.

1 Comment

image: Clocks Versus Rocks

Clocks Versus Rocks

By | January 14, 2014

A new analysis suggests that placental mammals originated while dinosaurs were dominant, contradicting a recent high-profile study.

3 Comments

image: Group Aims for Biomarker Standards

Group Aims for Biomarker Standards

By | January 14, 2014

A new alliance between industry, academia, and the government wants to boost the “dismal” success rate of biomarker development.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Ingenuity
Ingenuity

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies